India genetic testing market size reached USD 1.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.8 Billion by 2033, exhibiting a growth rate (CAGR) of 6.75% during 2025-2033. The continuous advancements in sequencing technologies, such as next-generation sequencing (NGS), which have made genetic testing more accessible and cost-effective, are driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 1.8 Billion |
Market Forecast in 2033 | USD 17.8 Billion |
Market Growth Rate (2025-2033) | 6.75% |
Genetic testing is a medical diagnostic tool that analyzes an individual's DNA to identify genetic variations associated with specific conditions or traits. By examining genes, chromosomes, and proteins, genetic testing can provide valuable information about an individual's risk for certain diseases, potential response to medications, and ancestry. It plays a crucial role in identifying genetic disorders, guiding personalized treatment plans, and assessing the likelihood of passing on inherited conditions to future generations. This non-invasive procedure can be conducted through techniques like polymerase chain reaction (PCR) or next-generation sequencing. While genetic testing offers insights into hereditary factors, it also raises ethical considerations regarding privacy, consent, and the potential psychological impact of results. Advances in genetic testing continue to contribute to precision medicine, allowing for tailored healthcare interventions based on an individual's unique genetic makeup.
The genetic testing market in India is witnessing substantial growth, driven by various factors that collectively underscore the increasing demand for genetic testing services. Firstly, advancements in technology have propelled the development of more sophisticated and cost-effective testing methods. As a result, the accessibility of genetic testing has expanded, making it more feasible for individuals to explore their genetic makeup. Additionally, the rising prevalence of genetic disorders and the growing awareness of the importance of early disease detection contribute significantly to market expansion. Furthermore, collaborative efforts between research institutions, pharmaceutical companies, and diagnostic laboratories have fostered innovation in genetic testing, leading to the introduction of novel testing modalities. Moreover, the integration of genetic testing into mainstream healthcare practices and the customization of treatment plans based on genetic insights are pivotal drivers for market growth. The expanding scope of genetic testing applications, spanning areas such as personalized medicine, prenatal screening, and cancer diagnostics, further amplifies market demand. The increasing trend of direct-to-consumer genetic testing services and the evolving regulatory landscape also play crucial roles in shaping the trajectory of the genetic testing market. In essence, a confluence of technological breakthroughs, healthcare awareness, and collaborative initiatives propels the genetic testing market forward in India, promising a future where genetic insights become integral to personalized healthcare strategies.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on type, technology, and application.
Type Insights:
The report has provided a detailed breakup and analysis of the market based on the type. This includes predictive and presymptomatic testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, and others.
Technology Insights:
A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes cytogenetic testing and chromosome analysis, biochemical testing, and molecular testing (DNA sequencing and others).
Application Insights:
The report has provided a detailed breakup and analysis of the market based on the application. This includes cancer diagnosis, genetic disease diagnosis, cardiovascular disease diagnosis, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, West and Central India, South India, and East and Northeast India.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Types Covered | Predictive and Presymptomatic Testing, Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Others |
Technologies Covered |
|
Applications Covered | Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, Others |
Regions Covered | North India, West and Central India, South India, East and Northeast India |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: